drug names (L4-8) Flashcards
hemicholinium 3
cholinergic transmission at neuromuscular junction:
synthesis step is initiatied by the reuptake of choline. which is Na+ dependent
this is blocked by hemicholiniom 3 (blocks the pump - so twitches in the muscles will fade away since there is not ACh being synthesised)
(not used clinically)
vesicamol
cholinergic transmission at neuromuscular junction:
storage step - Uptake and storage of ACh in synaptic vesicles is inhibited by vesamicol
(not used clinically)
Pump can be inhibited by vesamicol. Slowly will develop a block of the muscle twitches because no ACh is pumped into vesicles
Tetrodotoxin (TTX)
cholinergic transmission at neuromuscular junction:
release step - Tetrodotoxin (TTX) blocks voltage-gated Na+ channels
(no action potential – no release)
conatoxins
cholinergic transmission at neuromuscular junction:
release step - P/Q & N-type voltage-gated
Ca2+ channels are blocked by conatoxins
(no Ca2+ influx – no release)
Botulinum toxin
cholinergic transmission at neuromuscular junction:
release step - Botulinum toxin blocks vesicle fusion – no release
inhibits the fusion process - toxin will destroy the proteins involved in the fusion of vesicles
Causes paralysis
Dendrotoxins
cholinergic transmission at neuromuscular junction:
release step - Dendrotoxins block voltage-gated K+ channels (more Ca2+ influx – more release)
AP doesn’t repolarise, prolonged depolarization, more CA influx, constant neurotransmitter release
Ziconotide
Ziconotide acts as a selective N-type voltage-gated calcium channel blocker.
Given via the intrathecal route for the management of severe pain (directly through the spinal cord)
clinical uses of Botulinum toxin
muscular spasms are resistant to other treatments
Give injection of botulinum toxin to prevent activity of neuromuscular junction there
children with cerebral palsy and this toxin can be used as treatment as well
overactivation of the neuromuscular junction could cause drooling or sweating
α-latrotoxin
black widow spider venom
With α-LTX - huge amount of release of neurotrans, muscles spams (black widow spider overcomes its prey like this)
After - stops the endocytosis process, so vesicle membranes are not taken back, no more vesicles produced, desensitisation of receptors of presynaptic membrane, paralysis
nerve gases or neostigmine (different drugs, same effect)
Drugs that inhibit AChE, anticholinesterases (eg nerve gases, neostigmine) increase the concentration and effects of ACh -can lead to muscle spasms
Tubocurarine
found in vines of amazons, effective antagonist of receptors at neuromuscular junction, competitive antagonist
so if you increase the conc of ACh by inhibiting the enzyme that breaks it down, you can overcome the effect of tubocurarine
arrow poison – kills prey by respiratory paralysis
clinical side effects – decreased BP due to ganglion block & resultant vasodilatation
alpha bungarotoxin
Non depolarising because they are antagonists and block the receptors (like alpha bungarotoxin, found in the taiwanese snake, it binds to the same place as acetylcholine so should be competitive with tubocurarine, but it sticks covalently to the binding site so it cannot come off)
Vecuronium and rocuronium
used clinically because during an operation, we dont want muscle twitches. used for anaesthetics (safer because used at low doses)
Very rapid onsets, so for urgent surgeries
Reversed by anticholinesterases by poisoning it
suxamethonium
depolarising blocker - agonist
used clinically
rapid onset of paralysis
short duration – broken down by plasmacholinesterases
tracheal intubation, electroconvulsive therapy
BUT
side effects include:
bradycardia (decreased heart rate) due to M2 mAChR activation in heart
K+ release in trauma (eg burns) – cardiac dysrhythmias & cardiac arrest
prolonged paralysis (2hr+) in 1:3500 people
κ-bungarotoxin
irreversible (like α-bungarotoxin at NMJ)
trimethaphan
competitive antagonist
occasionally used in surgery for controlled hypotension & hypertensive crises
hexamethonium & tubocurarine
non competitive-open channel blockers
(drug sits in channel like plug in a bottle)
(compare with tubocurarine at NMJ-competitive)
hexamethonium used to reduce blood pressure
tubocurarine blocks the binding site of ach
nicotine & lobeline
ACh nicotinic receptor (nAChR) agonists
Lobeline - selective for ganglionic & chromaffin cell nAChR
repeatedly stimulate receptors
inactivate voltage-gated Na+ channels
desensitise nAChR receptors
not broken down by AChE
not used clinically as ganglion blockers – but nicotine (and varenicline - α4β2 nAChR) for tobacco addiction…
Ganglionic non-depolarising blockers (antagonists)
κ-bungarotoxin
trimethaphan
hexamethonium
tubocurarine